For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
After finishing at $66.33 in the prior trading day, Dexcom Inc (NASDAQ: DXCM) closed at $66.86, up 0.80%. In other words, the price has increased by $0.80 from its previous closing price. On the day, 4.52 million shares were traded.
Ratios:
Our goal is to gain a better understanding of DXCM by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 10.16 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 41.57. For the most recent quarter (mrq), Quick Ratio is recorded 1.28 and its Current Ratio is at 1.47. In the meantime, Its Debt-to-Equity ratio is 1.23 whereas as Long-Term Debt/Eq ratio is at 0.65.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Mizuho on April 10, 2025, initiated with a Outperform rating and assigned the stock a target price of $85.
On February 03, 2025, Redburn Atlantic Upgraded its rating to Buy which previously was Neutral and also upped its target price recommendation from $85 to $115.
Robert W. Baird Upgraded its Neutral to Outperform on January 16, 2025, whereas the target price for the stock was revised from $86 to $104.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 17 ’25 when Heller Bridgette P sold 352 shares for $70.33 per share. The transaction valued at 24,756 led to the insider holds 22,997 shares of the business.
Heller Bridgette P bought 352 shares of DXCM for $24,756 on Mar 17 ’25. On Mar 12 ’25, another insider, Leach Jacob Steven, who serves as the EVP, Chief Operating Officer of the company, sold 14,076 shares for $70.38 each. As a result, the insider received 990,670 and left with 313,497 shares of the company.
Valuation Measures:
As of this moment, Dexcom’s Price-to-Earnings (P/E) ratio for their current fiscal year is 46.93, and their Forward P/E ratio for the next fiscal year is 27.02. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 2.08. For the stock, the TTM Price-to-Sale (P/S) ratio is 6.50 while its Price-to-Book (P/B) ratio in mrq is 12.42.
Stock Price History:
Over the past 52 weeks, DXCM has reached a high of $139.24, while it has fallen to a 52-week low of $57.52. The 50-Day Moving Average of the stock is -10.84%, while the 200-Day Moving Average is calculated to be -13.69%.
Shares Statistics:
A total of 390.70M shares are outstanding, with a floating share count of 386.62M. Insiders hold about 1.40% of the company’s shares, while institutions hold 92.64% stake in the company.
